Boston Scientific Corporation BSX
43.92
(0.76)
(1.70%)
as of 25 Sep
- Market cap
- $64.7B
- P/E
- 17.7×
Follow BSX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Boston Scientific Corporation (BSX) Gross margin
Boston Scientific Corporation's gross margin over the twelve months to 30 June 2026 was 69.9%, up 0.9 percentage points from fiscal 2025 (69.0%). Over the past ten years it has ranged from 65.1% (fiscal 2020) to 71.4% (fiscal 2018); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of 56.0% and above the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 69.0% | 0.40 |
| FY2024 | 68.6% | (0.88) |
| FY2023 | 69.5% | 0.68 |
| FY2022 | 68.8% | 0.03 |
| FY2021 | 68.8% | 3.73 |
| FY2020 | 65.1% | (5.92) |
| FY2019 | 71.0% | (0.39) |
| FY2018 | 71.4% | 0.02 |
| FY2017 | 71.3% | 0.25 |
| FY2016 | 71.1% | 0.15 |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 70.7% | 1.27 |
| Mar 2026 | 69.4% | (0.13) |
| Dec 2025 | 69.6% | (0.36) |
| Sep 2025 | 69.9% | 2.28 |
| 42 more quarters | Free account |
Against its own ten years
Low 65.1%
High 71.4%
Ten-year median
69.5%
Current reading's percentile
45
Gross margin against peers
| Company | Gross margin |
|---|---|
| EW Edwards Lifesciences Corporation compare | 77.8% |
| BSX Boston Scientific Corporation | 69.9% |
| MDT Medtronic PLC compare | 65.0% |
| SYK Stryker Corporation compare | 65.0% |
| DXCM DexCom, Inc. compare | 62.5% |
| ABT Abbott Laboratories compare | 56.6% |
| PHG Koninklijke Philips N.V. compare | 45.9% |
| STE STERIS plc compare | 44.4% |
| GEHC GE HealthCare Technologies Inc. compare | 39.5% |
| Medical Devices industry median | 56.0% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BSX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement